Furazolidone

呋喃唑酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFurazolidone
Drug Alias NamefurazolidonafurazolidonefurazolidonumFuroxone
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Nitrofuran antibiotics
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsEnteritisDysenteryTrichomonas Infections +[6] 
Global Approved IndicationsEnteritisDysenteryTrichomonas Infections +[6] 
Approved Indications in ChinaEnteritisDysenteryTrichomonas Infections +[6] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesXinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsEnteritisDysenteryTrichomonas Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeG01AX06
Related LinksWikipediaDrugBankKEGG